What does bioleum — gain loss on sale of royalty rights mean?

Records the net financial impact resulting from the divestiture or sale of royalty interests associated with Bioleum assets. This metric highlights non-recurring gains or losses that impact the segment's overall financial performance.

Comstock Inc. LODE Bioleum — Gain Loss On Sale Of Royalty Rights

Similar metrics at other companies

CATXRoyalty — Gain Loss On Sales Of Assets And Asset Impairment Charges

$200K—

FBPGain Loss On Sale Of Loans And Leases

$1.84M+159%

HXLGain Loss On Divestiture Of Assets

-$1.23M—

FBPGain (Loss) on Sale of Loans and Leases

$1.84M+159%

XRXGain (Loss) On Sale Of Business And Property, Plant And Equipment

-$2M-167%

RWTGain/Loss on Asset Sales

$0-100%

Other financials

Income statement

See full

Revenue$313.5K-60.1%

Gross profit-$286.4K-184%

Operating income-$8.9M-27.1%

Net income-$9.4M-3.2%

EPS (diluted)-$3.01-450%

Balance sheet

See full

Cash & equivalents$53.0M+212%

Total debt$257.3K-98.8%

Total equity$156.4M—

Total assets$218.1M+28.6%

Cash flow

See full

Operating cash flow-$5.8M-17.3%

CapEx--100%

Free cash flow-$3.5M+2.7%

Valuation

See full

Market cap$302.13M+177%

Enterprise value$249.42M+118%

P/S279.4×+247×

Profitability

See full

Gross margin-116.4%-177pp

Operating margin-3,703.7%-7,510pp

Net margin-4,010%-13,152pp

FCF margin-462.3%-171pp

Returns & leverage

See full

Return on equity-51.5%-12.9pp

Debt / equity0×—

Current ratio4.5×+2.1×

Where this comes from

Reported directly by Comstock Inc. in its filing.

Tagged under the XBRL concept lode:GainLossOnSaleOfRoyaltyRights.

The official record: Comstock Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Comstock Inc.'s bioleum — gain loss on sale of royalty rights.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Comstock Inc.'s bioleum — gain loss on sale of royalty rights?: Comstock Inc. (LODE) reported bioleum — gain loss on sale of royalty rights of -$0 in Q1 2026.
What does bioleum — gain loss on sale of royalty rights mean?: Records the net financial impact resulting from the divestiture or sale of royalty interests associated with Bioleum assets. This metric highlights non-recurring gains or losses that impact the segment's overall financial performance.